Eli Lilly and Company Working Capital to Net Assets Ratio
Eli Lilly and Company working capital to net assets ratio. Eli Lilly and Company (LILY34) has a Working Capital to Net Assets ratio of 58.3% as of March 2026. Working capital of R$18.20 Billion (current assets of R$54.84 Billion minus current liabilities of R$36.63 Billion) is measured against net assets of R$31.20 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Eli Lilly and Company (2014–2025)
Working capital to net assets ratio of Eli Lilly and Company from 2014 to 2025. This chart shows how Eli Lilly and Company's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 58.3%, reflecting working capital of R$18.20 Billion against net assets of R$31.20 Billion BRL. Explore long-term investment intensity of Eli Lilly and Company to see how much of total assets are deployed in long-term investments.
Eli Lilly and Company Working Capital to Net Assets Ratio by Year (2014–2025)
Eli Lilly and Company working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Eli Lilly and Company from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Eli Lilly and Company balance sheet assets.
| Year | WC/NA Ratio | Working Capital (BRL) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 76.9% | R$20.40 Billion | R$26.54 Billion | R$55.63 Billion | R$35.23 Billion | ▲ +46.3 pp |
| 2024 | 30.6% | R$4.36 Billion | R$14.27 Billion | R$32.74 Billion | R$28.38 Billion | ▲ +45.0 pp |
| 2023 | -14.4% | R$-1.57 Billion | R$10.86 Billion | R$25.73 Billion | R$27.29 Billion | ▼ -22.8 pp |
| 2022 | 8.4% | R$896.30 Million | R$10.65 Billion | R$18.03 Billion | R$17.14 Billion | ▼ -28.7 pp |
| 2021 | 37.1% | R$3.40 Billion | R$9.15 Billion | R$18.45 Billion | R$15.05 Billion | ▼ -51.1 pp |
| 2020 | 88.3% | R$4.98 Billion | R$5.64 Billion | R$17.46 Billion | R$12.48 Billion | ▲ +14.1 pp |
| 2019 | 74.2% | R$1.93 Billion | R$2.61 Billion | R$13.71 Billion | R$11.78 Billion | ▼ -13.9 pp |
| 2018 | 88.1% | R$8.66 Billion | R$9.83 Billion | R$20.55 Billion | R$11.89 Billion | ▲ +47.9 pp |
| 2017 | 40.3% | R$4.67 Billion | R$11.59 Billion | R$19.20 Billion | R$14.54 Billion | ▲ +10.9 pp |
| 2016 | 29.4% | R$4.11 Billion | R$14.01 Billion | R$15.10 Billion | R$10.99 Billion | ▼ -0.4 pp |
| 2015 | 29.8% | R$4.34 Billion | R$14.59 Billion | R$12.57 Billion | R$8.23 Billion | ▲ +15.6 pp |
| 2014 | 14.2% | R$2.19 Billion | R$15.39 Billion | R$11.93 Billion | R$9.74 Billion | — |